Jacobson Pharma Corporation Limited
2633.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.94B
Close$
Share Statistics
| Market cap | $1.94 Billion |
|---|---|
| Enterprise Value | $2.51 Billion |
| Dividend Yield | $0.09 (9.28%) |
| Earnings per Share | $0.15 |
| Beta | 0.22 |
| Outstanding Shares | 1,999,774,000 |
Return
| Return on Equity | 26.01% |
|---|---|
| Return on Assets | 16.90% |
| Return on Invested Capital | 27.74% |
Valuation & Multiples
| P/E Ratio | 6.42 |
|---|---|
| PEG | -1073.16 |
| Price to Sales | 0.96 |
| Price to Book Ratio | 0.96 |
| Enterprise Value to Revenue | 0.8 |
| Enterprise Value to EBIT | 3.17 |
| Enterprise Value to Net Income | 4 |
| Total Debt to Enterprise | 0.37 |
| Debt to Equity | 0.4 |
Revenue Sources
No data
Insider Trades
Next Earnings Call
Expected Date
November 20, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$821.02 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Jacobson Pharma Corporation Limited
1,768 employees
CEO: Kwong Yip Sum Jacobson Pharma Corporation Limited, a subsidiary of Kingshill Development Limited, specializes in the production, promotion, and distribution of generic medications and branded healthcare products. Its market reach extends across Hong K...